Spatial Genomics, Inc.
Pasadena, CA SG
- UEI
- C2CPGG8RZLV9
- CAGE
- 7RHK6
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 145 Vista Ave STE 111, Pasadena, CA 91107, USA
- Website
- spatialgenomics.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Spatial Genomics, Inc. is a for-profit corporate entity registered in SAM.gov, specializing in advanced genomic technologies with a focus on spatial genomics and molecular imaging techniques. The company is headquartered in Pasadena, California, and operates through its SG Division, developing cutting-edge genomic research tools and platforms that enable high-resolution gene expression analysis. Spatial Genomics provides sophisticated scientific instrumentation and research technologies primarily through federal grant awards, with a particular emphasis on developing next-generation genomic imaging systems that can map gene expression across complex tissue samples.
The company has secured multiple significant federal grant awards from prominent research agencies, including the National Institute of Mental Health, National Institute on Aging, and National Cancer Institute. These awards, totaling over $2.4 million, focus on developing advanced spatial genomics technologies for analyzing brain tissues, tumor microenvironments, and complex cellular interactions. Specifically, Spatial Genomics has been developing its Gene Positioning System (GenEPS) platform, which utilizes sequential fluorescence in situ hybridization (seqFISH) technology to image up to 10,000 genes directly in tissue samples. Their research projects aim to create innovative reagents and instrumentation that enable detailed spatial mapping of gene expression in neurological disorder research, Alzheimer's disease studies, and cancer diagnostics, with a core objective of understanding cellular interactions, identifying novel cell types, and revealing spatial organization of cellular groups at unprecedented resolution.
Quick answers
Is Spatial Genomics, Inc. registered in SAM.gov?
Yes. Spatial Genomics, Inc.'s SAM.gov registration is active through December 10, 2026.
What is Spatial Genomics, Inc.'s CAGE code?
Spatial Genomics, Inc.'s CAGE code is 7RHK6, and its Unique Entity ID (UEI) is C2CPGG8RZLV9.
What is Spatial Genomics, Inc.'s most recent federal award?
Spatial Genomics, Inc.'s most recent federal grant award is Next generation spatial genomics tools for the human brain (R44MH140731), from National Institute of Mental Health (NIH), on June 1, 2025.
On GovTribe
See Spatial Genomics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors